The Use of Cost-effectiveness Analysis in Plastic Surgery Clinical Research

Clinics in Plastic Surgery

Volumn 35, Issue 2, 2008, Pages 285-296

  Thoma, Achilleas ^a,b   Strumas, Nick ^a   Rockwell, Gloria ^c   McKnight, Leslie ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEEP INFERIOR EPIGASTRIC PERFORATOR FLAP; ECONOMIC EVALUATION; PLASTIC SURGERY; QUALITY ADJUSTED LIFE YEAR; REVIEW; SENSITIVITY ANALYSIS; SUPERFICIAL INFERIOR EPIGASTRIC ARTERY FLAP; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP;

BIOMEDICAL RESEARCH; COST-BENEFIT ANALYSIS; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; RESEARCH DESIGN; SURGERY, PLASTIC;

EID: 39449114890     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2007.10.012     Document Type: Review

References (24)

1. Gold M.R., Siegel J.E., Russell L.B., et al. Cost-effectiveness in heath and medicine (1996), Oxford University Press
2. Taira D.A., Seto T.B., Seigrist R., et al. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J 145 (2003) 452-458
3. Drummond M.F., Sculpher M.J., Torrance G.W., et al. Methods for the economic evaluation of health care programmes. 3rd edition (2005), Oxford University Press, New York
4. Thoma A., Sprague S., and Tandan V. Users guide to the surgical literature: how to use an article on economic analysis. Can J Surg 44 (2001) 347-354
5. Russell L.B., Gold M.R., Siegel J.E., et al. The role of cost-effectiveness analysis in health and medicine: panel on cost-effectiveness in health and medicine. J Am Med Assoc 276 (1996) 1172
6. Koshima I., Inagawa K., Yamamoto M., et al. New microsurgical breast reconstruction using free paraumbilical perforator adiposal flaps. Plast Reconstr Surg 106 (2000) 61
7. Sinclair J.C., Torrance G.W., Boyle M.H., et al. Evaluation of neonatal-intensive-care program. N Engl J Med 305 (1981) 489-494
8. Kaplan R.M. Health outcome models for policy analysis. Health Psychol 8 (1989) 723-735
9. Cugno S., Sprague S., Duku E., et al. Composite tissue allotransplantation of the face: decision analysis model. Canadian Journal of Plastic Surgery 15 3 (2007) 145-152
10. Thoma A., Veltri K., Haines T., et al. A methodological guide to performing a cost-utility study comparing surgical techniques. Can J Plast Surg 12 (2004) 179-187
11. O'Brien B.J. Assessing the value of a new pharmaceutical: a feasibility study of contingent valuation in managed care. Med Care 36 3 (1998) 370-384
12. O'Brien B.J., and Gafni A. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making 16 (1996) 288-299
13. Drummond M.F., Richardson W.S., O'Brien B.J., et al. Users' guide to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. J Am Med Assoc 277 (1997) 1552-1557
14. Thoma A., Veltri K., Khuthaila D., et al. Comparison of the deep inferior epigastric perforator (DIEP) and free transverse rectus abdominis myocutaneous (TRAM) flap in post-mastectomy reconstruction: a cost-effectiveness analysis. Plast Reconstr Surg 113 (2004) 1650
15. Drummond M.F., O'Brien B.J., Stoddart G.L., et al. Methods for the economic evaluation of health care programmes. 2nd edition (1997), Oxford University Press, New York
16. Laupacis A., Feeny D., Detsky A.S., et al. How attractive does a technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 146 (1992) 473-481
17. Asim O., and Petrou S. Valuing a QALY: review of current controversies. Expert Review of Pharmacoeconomics & Outcomes Research 5 (2005) 667-669
18. McGregor M., and Caro J.J. QALYs: are they helpful to decision makers?. Pharmacoeconomics 24 (2006) 947-952
19. Vijan S. Should we abandon QALYs as a resource allocation tool?. Pharmacoeconomics 24 (2006) 953-954
20. Pearson S.D., and Rawlins M.D. Quality, innovation, and value for money: NICE and the British National Health Service. J Am Med Assoc 294 (2005) 2618-2622
21. Buxton M.J. Economic evaluation and decision making in the UK. Pharmacoeconomics 24 (2006) 1133-1142
22. Jakab E., Ganos D., and Cook F.W. Transverse carpal ligament reconstruction in surgery for carpal tunnel syndrome. A new technique. J Hand Surg (Am) 16 (1991) 202-206
23. Gafni A., and Birch S. Inclusion of drugs in provincial drug benefit programs: should "reasonable decisions" lead to uncontrolled growth in expenditures?. CMAJ 168 7 (2003) 849-851
24. Rockwell G., and Thoma A. Should the donor radius be plated prophylactically after harvest of a radial-forearm osteocutaneous flap?. J Reconstr Microsurg 20 (2004) 297